
Christian C. Boesen
Examiner (ID: 19338, Phone: (571)270-1321 , Office: P/1639 )
| Most Active Art Unit | 1639 |
| Art Unit(s) | 4131, 1684, 1636, 1675, 1639 |
| Total Applications | 1001 |
| Issued Applications | 687 |
| Pending Applications | 83 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17214821
[patent_doc_number] => 20210348158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
[patent_app_type] => utility
[patent_app_number] => 17/308167
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308167 | Integral membrane protein display on poxvirus extracellular enveloped virions | May 4, 2021 | Issued |
Array
(
[id] => 17037199
[patent_doc_number] => 20210254157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Immuno-PETE
[patent_app_type] => utility
[patent_app_number] => 17/307912
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 464
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307912 | Immuno-PETE | May 3, 2021 | Issued |
Array
(
[id] => 17198699
[patent_doc_number] => 20210338793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => PLASMIDS AND METHODS FOR PEPTIDE DISPLAY AND AFFINITY-SELECTION ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES
[patent_app_type] => utility
[patent_app_number] => 17/244255
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244255 | PLASMIDS AND METHODS FOR PEPTIDE DISPLAY AND AFFINITY-SELECTION ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES | Apr 28, 2021 | Abandoned |
Array
(
[id] => 17007426
[patent_doc_number] => 20210238587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => mRNA display antibody library and methods
[patent_app_type] => utility
[patent_app_number] => 17/236978
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236978 | MRNA display antibody library and methods | Apr 20, 2021 | Issued |
Array
(
[id] => 18452076
[patent_doc_number] => 20230193355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/996195
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996195 | METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS | Apr 14, 2021 | Pending |
Array
(
[id] => 17444124
[patent_doc_number] => 20220064629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Cellular Libraries of Peptide Sequences (CLiPS) and Methods of Using the Same
[patent_app_type] => utility
[patent_app_number] => 17/227738
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227738 | Cellular Libraries of Peptide Sequences (CLiPS) and Methods of Using the Same | Apr 11, 2021 | Abandoned |
Array
(
[id] => 19020453
[patent_doc_number] => 20240076624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Methods and Tools for Studying Enteroendocrine Cells
[patent_app_type] => utility
[patent_app_number] => 17/915771
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915771 | Methods and Tools for Studying Enteroendocrine Cells | Mar 30, 2021 | Pending |
Array
(
[id] => 18628528
[patent_doc_number] => 20230287394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => BARCODABLE EXCHANGEABLE PEPTIDE-MHC MULTIMER LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 17/995074
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995074 | BARCODABLE EXCHANGEABLE PEPTIDE-MHC MULTIMER LIBRARIES | Mar 30, 2021 | Pending |
Array
(
[id] => 18347561
[patent_doc_number] => 20230135671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/914373
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914373 | USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS | Mar 29, 2021 | Pending |
Array
(
[id] => 18737819
[patent_doc_number] => 20230346717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => IDENTIFICATION AND USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
[patent_app_type] => utility
[patent_app_number] => 17/906940
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906940 | IDENTIFICATION AND USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | Mar 25, 2021 | Pending |
Array
(
[id] => 20849923
[patent_doc_number] => 12686948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Construction method and application of antigen-specific binding polypeptide gene display vector
[patent_app_type] => utility
[patent_app_number] => 17/914650
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 14338
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 607
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914650 | CONSTRUCTION METHOD AND APPLICATION OF ANTIGEN-SPECIFIC BINDING POLYPEPTIDE GENE DISPLAY VECTOR | Mar 25, 2021 | Issued |
Array
(
[id] => 18709257
[patent_doc_number] => 20230331871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF MAMMALIAN CELL AND VECTOR
[patent_app_type] => utility
[patent_app_number] => 17/914796
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914796 | METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF MAMMALIAN CELL AND VECTOR | Mar 25, 2021 | Abandoned |
Array
(
[id] => 17260013
[patent_doc_number] => 20210372998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHODS AND SYSTEMS FOR ANTIGEN SCREENING
[patent_app_type] => utility
[patent_app_number] => 17/209045
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 183776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209045 | METHODS AND SYSTEMS FOR ANTIGEN SCREENING | Mar 21, 2021 | Abandoned |
Array
(
[id] => 18754352
[patent_doc_number] => 20230357754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => RAPID EXTRACELLULAR ANTIBODY PROFILING (REAP) FOR THE DISCOVERY AND USE OF SAID ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/906759
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906759 | RAPID EXTRACELLULAR ANTIBODY PROFILING (REAP) FOR THE DISCOVERY AND USE OF SAID ANTIBODIES | Mar 21, 2021 | Pending |
Array
(
[id] => 18421586
[patent_doc_number] => 20230176049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Pan-Isotype Immunoglobulin Fingerprinting
[patent_app_type] => utility
[patent_app_number] => 17/913220
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913220 | Pan-Isotype Immunoglobulin Fingerprinting | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17215738
[patent_doc_number] => 20210349076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => IN VITRO TOXICITY SCREENING ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/208870
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208870 | IN VITRO TOXICITY SCREENING ASSAY | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17421486
[patent_doc_number] => 11254931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Antibody libraries with maximized antibody developability characteristics
[patent_app_type] => utility
[patent_app_number] => 17/208877
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 21176
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 543
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208877 | Antibody libraries with maximized antibody developability characteristics | Mar 21, 2021 | Issued |
Array
(
[id] => 18312789
[patent_doc_number] => 20230116689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/906102
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -270
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906102 | METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES | Mar 17, 2021 | Abandoned |
Array
(
[id] => 17097204
[patent_doc_number] => 20210284995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => DIRECTED EVOLUTION OF SYNTHETIC GENE CLUSTER
[patent_app_type] => utility
[patent_app_number] => 17/204219
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204219 | Directed evolution of synthetic gene cluster | Mar 16, 2021 | Issued |
Array
(
[id] => 18283165
[patent_doc_number] => 20230098637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PROGNOSTIC PATHWAYS FOR HIGH RISK SEPSIS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/906296
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906296 | PROGNOSTIC PATHWAYS FOR HIGH RISK SEPSIS PATIENTS | Mar 10, 2021 | Abandoned |